This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BZAM Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on BZAM's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth
5.95%
Revenue growth rate
n/a
Return on equity
n/a
Net Margin
n/a
Last Earnings Update
30 Sep 2023
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How BZAM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:BZAM.F Revenue, expenses and earnings (CAD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 23
82
-106
43
0
30 Jun 23
71
-97
39
0
31 Mar 23
63
-40
34
0
31 Dec 22
49
-35
29
0
30 Sep 22
42
-33
26
0
30 Jun 22
39
-40
28
0
31 Mar 22
35
-66
28
0
31 Dec 21
30
-39
28
0
30 Sep 21
28
-48
27
1
30 Jun 21
23
-109
26
1
31 Mar 21
15
-85
26
1
31 Dec 20
13
-171
35
1
30 Sep 20
9
-301
48
1
30 Jun 20
9
-246
61
2
31 Mar 20
11
-254
71
2
31 Dec 19
11
-195
72
2
30 Sep 19
10
-69
70
2
30 Jun 19
7
-60
58
2
31 Mar 19
4
-52
49
3
01 Jan 19
2
-45
41
3
30 Sep 18
0
-33
29
3
30 Jun 18
0
-24
22
3
31 Mar 18
0
-18
17
2
31 Dec 17
0
-13
14
1
Quality Earnings: Insufficient data to determine if BZAM.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if BZAM.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BZAM.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare BZAM.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if BZAM.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: BZAM.F has a negative Return on Equity (0%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/10/27 10:38
End of Day Share Price
2025/10/27 00:00
Earnings
2023/09/30
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BZAM Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.